http://www.prnewswire.com/rss/health/clinical-trials-medial-discoveries-news.rss/ Press Releases from PR Newswire about Clinical Trials & Medical Discoveries en-us Sat, 25 May 2013 00:14:03 EDT Fri, 24 May 2013 08:16:00 EDT http://www.prnewswire.com/news-releases/volcano-stellt-bei-prasentationsveranstaltung-zu-jungsten-klinischen-studien-auf-der-europcr-2013-vorlaufige-ergebnisse-der-advise-ii-studie-vor-und-kundigt-aufnahme-in-syntax2-test-an-208805301.html http://www.prnewswire.com/news-releases/volcano-stellt-bei-prasentationsveranstaltung-zu-jungsten-klinischen-studien-auf-der-europcr-2013-vorlaufige-ergebnisse-der-advise-ii-studie-vor-und-kundigt-aufnahme-in-syntax2-test-an-208805301.html Fri, 24 May 2013 08:16:00 EDT de PR Newswire Association LLC. http://www.prnewswire.com/news-releases/pbac-approves-xifaxan-rifaxamin--550-mg-cost-effectiveness-in-australia-208796601.html http://www.prnewswire.com/news-releases/pbac-approves-xifaxan-rifaxamin--550-mg-cost-effectiveness-in-australia-208796601.html Fri, 24 May 2013 06:00:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/nuevas-investigaciones-identifican-la-conexion-entre-el-control-deficiente-del-asma-y-la-actitud-de-los-pacientes-en-europa-208782141.html http://www.prnewswire.com/news-releases/nuevas-investigaciones-identifican-la-conexion-entre-el-control-deficiente-del-asma-y-la-actitud-de-los-pacientes-en-europa-208782141.html Fri, 24 May 2013 02:30:00 EDT es PR Newswire Association LLC. http://www.prnewswire.com/news-releases/une-nouvelle-etude-revele-le-lien-entre-controle-inadequat-de-lasthme-a-travers-leurope-et-comportements-des-patients-208782161.html http://www.prnewswire.com/news-releases/une-nouvelle-etude-revele-le-lien-entre-controle-inadequat-de-lasthme-a-travers-leurope-et-comportements-des-patients-208782161.html Fri, 24 May 2013 02:30:00 EDT fr PR Newswire Association LLC. http://www.prnewswire.com/news-releases/neue-forschungsergebnisse-zeigen-verbindung-zwischen-suboptimaler-asthmaversorgung-und-patienteneinstellungen-in-europa-auf-208782181.html http://www.prnewswire.com/news-releases/neue-forschungsergebnisse-zeigen-verbindung-zwischen-suboptimaler-asthmaversorgung-und-patienteneinstellungen-in-europa-auf-208782181.html Fri, 24 May 2013 02:30:00 EDT de PR Newswire Association LLC. http://www.prnewswire.com/news-releases/volcano-anuncia-los-resultados-preliminares-del-estudio-advise-ii-y-su-inclusion-en-el-ensayo-syntax2-208745461.html http://www.prnewswire.com/news-releases/volcano-anuncia-los-resultados-preliminares-del-estudio-advise-ii-y-su-inclusion-en-el-ensayo-syntax2-208745461.html Thu, 23 May 2013 19:45:00 EDT es PR Newswire Association LLC. http://www.prnewswire.com/news-releases/volcano-annonce-les-resultats-preliminaires-de-letude-advise-ii-et-son-integration-a-lessai-syntax2-lors-des-dernieres-sessions-dessai-clinique-en-ligne-a-leuropcr-2013-208743971.html http://www.prnewswire.com/news-releases/volcano-annonce-les-resultats-preliminaires-de-letude-advise-ii-et-son-integration-a-lessai-syntax2-lors-des-dernieres-sessions-dessai-clinique-en-ligne-a-leuropcr-2013-208743971.html Thu, 23 May 2013 19:34:00 EDT fr PR Newswire Association LLC. http://www.prnewswire.com/news-releases/nuevos-datos-clinicos-presentados-en-europcr-demuestran-que-triguard-reduce-el-volumen-de-lesion-cerebral-durante-el-rvat-208730571.html http://www.prnewswire.com/news-releases/nuevos-datos-clinicos-presentados-en-europcr-demuestran-que-triguard-reduce-el-volumen-de-lesion-cerebral-durante-el-rvat-208730571.html Thu, 23 May 2013 18:04:00 EDT PARÍS y CAESAREA, Israel, 23 de mayo de 2013 /PRNewswire/ -- Nuevos datos clínicos presentados del estudio DEFLECT-I demuestran que el Dispositivo de Protección Cerebral (Cerebral Protection Device)  TriGuard™ de Keystone Heart reduce el volumen de...

]]>

]]> PRNewswire es PR Newswire Association LLC. http://www.prnewswire.com/news-releases/novos-dados-clinicos-apresentados-no-europcr-revelam-que-o-triguard-reduz-o-volume-de-lesoes-cerebrais-durante-o-tavi-208728001.html http://www.prnewswire.com/news-releases/novos-dados-clinicos-apresentados-no-europcr-revelam-que-o-triguard-reduz-o-volume-de-lesoes-cerebrais-durante-o-tavi-208728001.html Thu, 23 May 2013 17:51:00 EDT PARIS e CAESAREA, Israel, 23 de maio de 2013 /PRNewswire/ -- Novos dados clínicos apresentados no estudo do DEFLECT-I revelam que o TriGuard™, Dispositivo de Proteção Cerebral da Keystone Heart, reduz o volume das lesões cerebrais durante os...

]]>

]]> PRNewswire pt PR Newswire Association LLC. http://www.prnewswire.com/news-releases/first-large-scale-us-study-validates-the-benefits-of-3d-mammography-breast-tomosynthesis-exams-208704341.html http://www.prnewswire.com/news-releases/first-large-scale-us-study-validates-the-benefits-of-3d-mammography-breast-tomosynthesis-exams-208704341.html Thu, 23 May 2013 15:45:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/hadasit-bio-holdings-ltd-portfolio-company---cell-cure-neurosciences-ltd-received-additional-government-support-208700591.html http://www.prnewswire.com/news-releases/hadasit-bio-holdings-ltd-portfolio-company---cell-cure-neurosciences-ltd-received-additional-government-support-208700591.html Thu, 23 May 2013 15:22:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/puramed-bioscience-pmbs-issued-alert-based-on-market-cap-of-721756-208687241.html http://www.prnewswire.com/news-releases/puramed-bioscience-pmbs-issued-alert-based-on-market-cap-of-721756-208687241.html Thu, 23 May 2013 14:10:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/zensun-announces-positive-clinical-results-for-neucardintm-to-improve-heart-function-and-reduce-mortality-in-chronic-heart-failure-patients-208632041.html http://www.prnewswire.com/news-releases/zensun-announces-positive-clinical-results-for-neucardintm-to-improve-heart-function-and-reduce-mortality-in-chronic-heart-failure-patients-208632041.html Thu, 23 May 2013 13:45:00 EDT SAN DIEGO and SHANGHAI, May 23, 2013 /PRNewswire/ -- Zensun Sci & Tech, Ltd., a biopharmaceutical company based in Shanghai and San Diego, announced today positive results of four completed Phase 2 clinical trials including three double-blind, placebo-controlled studies...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/need-for-image-guided-minimally-invasive-ablative-treatments-featured-prominently-at-american-urological-association-aua-annual-meeting-208682721.html http://www.prnewswire.com/news-releases/need-for-image-guided-minimally-invasive-ablative-treatments-featured-prominently-at-american-urological-association-aua-annual-meeting-208682721.html Thu, 23 May 2013 13:44:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/die-bei-der-europcr-prasentierten-neuen-daten-zeigen-dass-triguard-das-volumen-von-hirnverletzungen-wahrend-tavr-operationen-reduziert-208678881.html http://www.prnewswire.com/news-releases/die-bei-der-europcr-prasentierten-neuen-daten-zeigen-dass-triguard-das-volumen-von-hirnverletzungen-wahrend-tavr-operationen-reduziert-208678881.html Thu, 23 May 2013 13:21:00 EDT PARIS und CAESAREA, Israel, May 23, 2013 /PRNewswire/ -- Die präsentierten neue klinische Daten von der DEFLECT-I-Studie zeigen, dass das Gerät TriGuard™ Cerebral Protection Device von Keystone Heart das Volumen von Hirnverletzungen während Operationen für...

]]>

]]> PRNewswire de PR Newswire Association LLC. http://www.prnewswire.com/news-releases/clinical-trial-tests-targeting-prostate-cancer-treatment-208661911.html http://www.prnewswire.com/news-releases/clinical-trial-tests-targeting-prostate-cancer-treatment-208661911.html Thu, 23 May 2013 11:52:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/de-nouvelles-donnees-cliniques-presentees-a-leuropcr-indiquent-que-triguard-reduit-le-volume-de-lesions-cerebrales-lors-dune-tavi-208655091.html http://www.prnewswire.com/news-releases/de-nouvelles-donnees-cliniques-presentees-a-leuropcr-indiquent-que-triguard-reduit-le-volume-de-lesions-cerebrales-lors-dune-tavi-208655091.html Thu, 23 May 2013 11:02:00 EDT PARIS et CÉSARÉE, Israël, May 23, 2013 /PRNewswire/ -- De nouvelles données cliniques provenant de l'étude DEFLECT-I indiquent que le dispositif de protection cérébrale TriGuard™ de la société Keystone Heart, permet de réduire le...

]]>

]]> PRNewswire fr PR Newswire Association LLC. http://www.prnewswire.com/news-releases/first-large-scale-population-based-study-in-the-us-shows-hologics-3d-mammography-breast-tomosynthesis-significantly-reduces-recall-rates-while-simultaneously-improving-cancer-detection-208649191.html http://www.prnewswire.com/news-releases/first-large-scale-population-based-study-in-the-us-shows-hologics-3d-mammography-breast-tomosynthesis-significantly-reduces-recall-rates-while-simultaneously-improving-cancer-detection-208649191.html Thu, 23 May 2013 10:28:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/intensified-liposomal-anthracycline-based-chemo-regimen-for-children-with-leukemia-may-offer-high-survival-rates-without-added-heart-toxicity-208647391.html http://www.prnewswire.com/news-releases/intensified-liposomal-anthracycline-based-chemo-regimen-for-children-with-leukemia-may-offer-high-survival-rates-without-added-heart-toxicity-208647391.html Thu, 23 May 2013 10:15:00 EDT en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/spring-bank-pharmaceuticals-initiates-a-phase-i-clinical-trial-for-sb-9200-in-hcv-infected-patients-208645181.html http://www.prnewswire.com/news-releases/spring-bank-pharmaceuticals-initiates-a-phase-i-clinical-trial-for-sb-9200-in-hcv-infected-patients-208645181.html Thu, 23 May 2013 10:00:00 EDT en-US PR Newswire Association LLC.